GridAI Technologies (GRDX) Change in Account Payables (2021 - 2025)
GridAI Technologies' (GRDX) quarterly Change in Account Payables came in at -$51462.0 in Q4 2025, down 106.91% YoY from $744302.0 in Q4 2024, and down 129.16% on a QoQ basis from $176463.0 in Q3 2025.
GridAI Technologies (GRDX) Change in Account Payables (2021 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 5 years of Change in Account Payables data on file, last reported at -$51462.0 in Q4 2025.
- Quarterly Change in Account Payables fell 106.91% year-over-year to -$51462.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $464200.0 (down 71.78% YoY) and the FY2025 annual result came in at $464200.0, down 71.78% from the prior year.
- Change in Account Payables fell to -$51462.0 in Q4 2025, from $176463.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.0 million in Q1 2022 to a low of -$2.9 million in Q4 2022.
- A 5-year average of -$114071.7 and a median of -$38238.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables sank 274.75% — and 2024, when it soared 3075.54%.
- Tracing GRDX's Change in Account Payables over 5 years: stood at -$763953.0 in 2021, then slumped by 274.75% to -$2.9 million in 2022, then jumped by 99.13% to -$25014.0 in 2023, then soared by 3075.54% to $744302.0 in 2024, then plunged by 106.91% to -$51462.0 in 2025.
- The last three Change in Account Payables figures came in at -$51462.0 (Q4 2025), $176463.0 (Q3 2025), and $448519.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | -51,462.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -51,462.00 |
| Dec 31, 2025 | -51,462.00 |
| Sep 30, 2025 | 176,463.00 |
| Sep 30, 2025 | 176,463.00 |
| Jun 30, 2025 | 448,519.00 |
| Jun 30, 2025 | 448,519.00 |
| Mar 31, 2025 | -109,320.00 |
| Mar 31, 2025 | -109,320.00 |
| Dec 31, 2024 | 744,302.00 |
| Dec 31, 2024 | 744,302.00 |
| Sep 30, 2024 | 155,952.00 |
| Sep 30, 2024 | 155,952.00 |
| Jun 30, 2024 | 218,561.00 |
| Jun 30, 2024 | 218,561.00 |
| Mar 31, 2024 | 526,033.00 |
| Mar 31, 2024 | 526,033.00 |
| Dec 31, 2023 | -25,014.00 |
| Dec 31, 2023 | -25,014.00 |
| Sep 30, 2023 | -1.01 Mn |
| Sep 30, 2023 | -1.01 Mn |